Pharmacodynamics of Camizestrant Treatment in Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer: Results From the Randomized, Presurgical SERENA-3 Study
AstraZeneca
John F R Robertson; Teimuraz Gogitidze; Zaza Katashvili; Juan Enrique Bargalló Rocha; Ekaterine Arkania; Iain Moppett; Kwok-Leung Cheung; Gia Nemsadze; Maxine Ajimi; Teresa Klinowska; Justin P O Lindemann; Alastair Mathewson; Christopher J Morrow; Myria Nikolaou; Maurizio Scaltriti; Andy Sykes; Giorgi Dzagnidze